| Reshma Kewalramani |
CEO & President, Director |
$70,191,462 |
+$3,895,768 |
+5.9% |
22 Jan 2026 |
| Amit Sachdev |
EVP Chief Patient & Ext Af Off |
$36,804,217 |
|
|
22 Jan 2026 |
| Stuart A. Arbuckle |
Evp, Coo |
$28,590,654 |
|
|
01 Jul 2025 |
| BRUCE I. SACHS |
Director |
$24,847,329 |
+$1,948,416 |
+8.5% |
15 Jan 2026 |
| Ourania Tatsis |
EVP, Chief Reg. & Quality Off. |
$24,500,481 |
-$8,429,264 |
-26% |
22 Jan 2026 |
| CHARLES F. WAGNER JR |
Evp, Co & Fo |
$23,268,702 |
-$12,427,252 |
-35% |
22 Jan 2026 |
| Carmen Bozic |
EVP and CMO |
$19,948,746 |
|
|
22 Jan 2026 |
| DAVID ALTSHULER |
EVP, Chief Scientific Officer |
$15,630,492 |
-$6,420,269 |
-29% |
22 Jan 2026 |
| JEFFREY M. LEIDEN |
Executive Chairman, Director |
$15,178,039 |
-$60,942,657 |
-80% |
22 Jan 2026 |
| Bastiano Sanna |
EVP, Cell & Genetic Therapies |
$13,426,165 |
|
|
05 May 2023 |
| Edward Morrow Atkinson III |
EVP, Chief Technical Ops. Off. |
$11,183,937 |
-$3,999,263 |
-26% |
22 Jan 2026 |
| Jonathan Biller |
EVP and Chief Legal Officer |
$11,050,196 |
-$2,769,093 |
-20% |
22 Jan 2026 |
| Duncan McKechnie |
EVP, Chief Commercial Officer |
$10,399,171 |
|
|
22 Jan 2026 |
| Mark E. Bunnage |
EVP, Chief Scientific Officer |
$7,281,868 |
|
|
01 Feb 2026 |
| Kristen Ambrose |
SVP & Chief Accounting Officer |
$5,483,389 |
-$1,363,231 |
-20% |
22 Jan 2026 |
| Joy Liu |
SVP, General Counsel |
$4,025,167 |
|
|
15 Aug 2022 |
| Alan M. Garber |
Director |
$3,728,290 |
|
|
01 May 2025 |
| DIANA MCKENZIE |
Director |
$3,594,392 |
|
|
01 May 2025 |
| Terrence C. Kearney |
Director |
$3,139,773 |
|
|
01 May 2024 |
| MARGARET G. MCGLYNN |
Director |
$2,947,202 |
|
|
01 May 2023 |
| LLOYD CARNEY |
Director |
$2,632,155 |
|
|
19 Nov 2025 |
| Suketu Upadhyay |
Director |
$2,345,736 |
|
|
15 Jan 2026 |
| Sangeeta N. Bhatia |
Director |
$1,765,239 |
-$305,204 |
-15% |
27 Aug 2025 |
| Yuchun Lee |
Director |
$1,229,723 |
|
|
01 May 2023 |
| Nancy Thornberry |
Director |
$1,185,752 |
|
|
01 May 2025 |
| Jennifer Schneider |
Director |
$831,889 |
|
|
01 May 2025 |
| Michel Lagarde |
Director |
$400,731 |
|
|
01 May 2025 |